LAKE OSWEGO, Ore., Sept. 30, 2013 /PRNewswire-iReach/ -- Medolac Laboratories (Neolac, Inc. dba) www.medolac.com, today announced the hiring of J. Douglas Hawkins as the company's Senior Vice President of Corporate Affairs. This new position was created to drive Medolac's corporate development efforts globally. Mr. Hawkins will be reporting directly to Medolac's founder, president and CEO, Elena Medo.
As the SVP of Corporate Affairs, Mr. Hawkins will be responsible for managing efforts to maximize Medolac's impact in global markets, including identifying and developing partnership, alliance and cooperative agreements with key corporate, government, hospital, international organizations and non-governmental organization (NGO) stakeholders. He also will be responsible for global public affairs and issues management.
In discussing Mr. Hawkins' appointment, Ms. Medo said, "We are extremely pleased that Doug is joining Medolac at such a critical point in our development. He brings a wealth of experience in developing global nutritional and pediatric vaccine assets. His corporate responsibility acumen, including a long history of forging successful public/private partnerships will be critical to our success. His leadership will provide a strategic, values-driven and sustainable approach to expand our product reach worldwide.
"I am delighted to join Medolac. Their innovative and ethical approach will greatly improve health outcomes for the most vulnerable among us, premature infants", stated Doug Hawkins. "The immense life-saving potential and the health economics of human milk adapted therapies are unrivaled, representing an unprecedented opportunity to reduce infant morbidity and mortality at this early life stage."
Mr Hawkins, 47, comes to Medolac from Pfizer/Wyeth Nutrition where he served as Vice President of Public Affairs and Policy for several years. During his tenure, Mr. Hawkins was responsible for overseeing corporate and government affairs at HQ and in key markets, including teams in several important South East Asia, greater China, Middle East and Latin America regions. He led successful efforts to implement Pfizer's responsible marketing commitments in a challenging compliance environment, led collaborative initiatives that positioned Pfizer Nutrition favorably amongst its peers, and successfully managed high profile issues affecting the business across the world. He also brings a wealth of experience from the multilateral public sector, having worked for more than a decade leading Treaty operations activities at the United Nations agency responsible for intellectual property in Geneva, Switzerland. He has chaired several committees including the PhRMA industry committee on global issues and served on various boards including the advisory board of the GW Law School Creative and Innovative Economy Center.
Medolac Laboratories (www.medolac.com) is a Delaware corporation (Neolac Inc. dba Medolac) headquartered at Lake Oswego, Oregon in the Pacific Northwest of the United States. Our vision is to provide human milk based therapies to critically ill babies and children on a global basis by applying proprietary biopharmaceutical processing methods that preserve the immune components in human milk while providing the safest, highest quality human milk formulations available to babies in need.
Media Contact: Yvonne Arroyo, Medolac Laboratories, 8665997740, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Medolac Laboratories